Clinical Trials Logo
  1. Home
  2. Obesity
  3. NCT05518422
  4. Details
NCT05518422 Clinical Trial

Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity

Obesity Clinical Trial

Official title:
Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT05518422
Other study ID # 2090413
Secondary ID
Status Withdrawn
Phase Early Phase 1
First received
Last updated
Start date February 2024
Est. completion date February 2024

Study information
Verified date February 2024
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this project is to determine role for ET-1 in individuals with obesity.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date February 2024
Est. primary completion date February 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - 18-55 years of age - Male sex - Obese (BMI =30 kg/m2) Exclusion Criteria: - Female sex - Current smoking/Nicotine use - Nerve/neurologic disease - Cardiovascular, hepatic, renal, respiratory disease - Blood pressure =140/90 mmHg - Diabetes - Vigorous exercise >3 times/week - Communication barriers - taking any medications known to affect metabolic, respiratory, cardiovascular, and/or autonomic

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Hyperinsulinemic, euglycemic infusion
60 minute infusion

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University of Missouri-Columbia

Outcome
Type Measure Description Time frame Safety issue
Primary Amount of muscle sympathetic nerve activity (MSNA) MSNA burst incidence (bursts/100 heart beats) Change from baseline at minute 60
Primary Amount of leg blood flow Measured with Doppler ultrasound (mL/min) Change from baseline at minute 60
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2